Racial differences in penicillin allergy delabeling in a multicenter US primary care cohort

美国多中心初级保健队列研究中青霉素过敏诊断取消标签的种族差异

阅读:1

Abstract

BACKGROUND: Penicillin allergy labels affect 1 in 10 people but are uncommonly reflective of a true, IgE-mediated allergy. Penicillin allergy-labeled patients have increased exposure to broad-spectrum antibiotics that increase the risk for treatment failures, antimicrobial resistance, and adverse events. Delabeling of penicillin allergy is an evidence-based strategy to support access to optimal antibiotics and reduce antimicrobial resistance. OBJECTIVE: To assess the association of race with penicillin allergy delabeling prevalence. METHODS: We used a retrospective cohort of primary care patients at Mass General Brigham and Tufts Medicine health systems receiving care from January 2019 to April 2022 with any active or inactive (ie, deleted or inactivated) penicillin allergy record in their electronic health record. We assessed penicillin allergy delabeled as the primary outcome, defined as no active penicillin allergy record in the electronic health record using a validated algorithm. The primary exposure was self-reported race in the electronic health record. We also assessed age, sex (at birth), language preference, documented allergies, health care visits, and Charlson comorbidity index as potential associated factors and mediators. RESULTS: Black patients were less likely to have penicillin allergy delabeling overall (adjusted odds ratio 0.73 [95% CI 0.64-0.84]), but the prevalence and mediation differed across the 2 health care systems. Asian patients had lower penicillin allergy delabeling prevalence (adjusted odds ratio 0.76 [95% CI 0.65-0.88]), which was mediated in both systems by non-English language preference and specific health care utilization. CONCLUSION: Racial differences were identified in penicillin allergy delabeling in Black and Asian patients, but with inconsistencies between health care systems. Further studies identifying the clinician-, institution-, and structural-level barriers to penicillin allergy delabeling are necessary to advance equitable penicillin allergy delabeling and antibiotic stewardship.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。